dc.contributor.author | Hussain, Yousra Zoulkifl | |
dc.date.accessioned | 2019-02-27T09:18:03Z | |
dc.date.available | 2019-02-27T09:18:03Z | |
dc.date.issued | 2018-05-05 | |
dc.identifier.uri | http://repository.limu.edu.ly/handle/123456789/554 | |
dc.description | Diabetes is the inability of our body to produce or use insulin. Insulin is a hormone
which allows your body to turn sugars and glucose to energy. So if a body has difficulty
in metabolizing glucose and sugar there will be decrease in energy production, prevent
oxygen and nutrients from energizing cells, prevent immune system from functioning
properly and hence delay wound healing and ulcers. There are many other factors that
contribute to delayed healing in such individuals like decreased or impaired growth
factor (GF) production, angiogenic response , macrophage function, collagen
accumulation and quantity of granulation tissue | en_US |
dc.description.abstract | The placenta has biological properties that are beneficial to the wound healing process
of diabetic foot ulcers (DFU) . It contains mesenchymal stems cells (MSCs). MSCs are
‘multipotent’, meaning they can produce several types of specialized cells, such as
cartilage, bone, and fat cells that can repair damage from illness or injury. The aim of
this report is to analyze the scientific evidence found in literature on the use of the
placenta membrane to stimulate DFU healing | en_US |
dc.language.iso | en | en_US |
dc.publisher | faculty of Basic Medical Science - Libyan International Medical University | en_US |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.title | Positive clinical outcomes of cryopreserved human placenta membrane in treatment of diabetic foot ulcers | en_US |
dc.type | Other | en_US |